(Q30870589)

27 June 2017

1 reference

title

Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands (English)

1 reference

27 June 2017

0 references

Serradeil-Le Gal C

1

1 reference

27 June 2017

Wagnon J

2

1 reference

27 June 2017

Valette G

3

1 reference

27 June 2017

Garcia G

4

1 reference

27 June 2017

Pascal M

5

1 reference

27 June 2017

Maffrand JP

6

1 reference

27 June 2017

Le Fur G

7

1 reference

27 June 2017

publication date

1 January 2002

1 reference

Progress in Brain Research

27 June 2017

published in

1 reference

27 June 2017

volume

139

1 reference

27 June 2017

page(s)

197-210

1 reference

Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

VACM-1, a cullin gene family member, regulates cellular signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Vascular responses to vasopressin antagonists in man and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Cloning and characterization of the human V3 pituitary vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Small molecule ligands for oxytocin and vasopressin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Alpha 2-adrenergic stimulation and vasopressin in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Expression of the genes encoding the vasopressin-activated calcium-mobilizing receptor and the dual angiotensin II/vasopressin receptor in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Stress-induced secretion of adrenocorticotropin in rats is inhibited by administration of antisera to ovine corticotropin-releasing factor and vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Molecular biology of vasopressin receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Nonpeptide vasopressin antagonists: a new group of hormone blockers entering the scene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Identification of a novel dual angiotensin II/vasopressin receptor on the basis of molecular recognition theory

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939017-4

7 January 2021

10.1016/S0079-6123(02)39017-4

Identifiers

DOI

1 reference

27 June 2017

1 reference